ALPHA TRIBE

Sun Pharmaceutical Industries LimitedUpdates, 26-11-2025: Press Release

26-11-2025 | 08:54 am

Sun Pharma's UNLOXCYT received FDA label update for advanced CSCC, showing improved clinical outcomes and durable responses. As the first PD-L1 inhibitor, this strengthens its market position, enhancing future revenue potential.

No comments yet. Be the first to comment!

All announcements from Sun Pharmaceutical Industries Limited